US Stock MarketDetailed Quotes

IMMX Immix Biopharma

Watchlist
  • 2.220
  • +0.120+5.71%
Close Dec 19 16:00 ET
  • 2.100
  • -0.120-5.41%
Post 20:01 ET
61.07MMarket Cap-2.64P/E (TTM)

About Immix Biopharma Company

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Company Profile

SymbolIMMX
Company NameImmix Biopharma
Listing DateDec 16, 2021
Issue Price5.00
Founded2012
CEODr. Ilya Rachman
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address11400 West Olympic Boulevard,Suite 200
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90064
Phone1-310-651-8041
Websitehttp://www.immixbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Vladimir Torchilin
  • Scientific Co-Founder
  • --
  • Dr. Ilya Rachman
  • Chairman of the Board and Chief Executive Officer
  • 2.36M
  • Gabriel Morris
  • Chief Financial Officer, Principal Accounting Officer and Director
  • 2.36M
  • Dr. Graham Ross
  • Acting Chief Medical Officer and Head of Clinical Development
  • --
  • Jason Hsu
  • Director
  • 79.30K
  • Dr. Carey Ng
  • Independent Director
  • 82.80K
  • Jane M. Buchan, PhD
  • Independent Director
  • 95.80K
  • Helen C. Ada C.P.A.
  • Independent Director
  • 98.15K
  • Dr. Magda Marquet, PhD
  • Independent Director
  • 89.30K
  • Yekaterina Chudnovsky
  • Independent Director
  • --
  • Nandan Oza
  • Head of Chemistry, Manufacturing, and Control
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data